The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function

被引:11
作者
Murray, Lindsey T. [1 ]
Leidy, Nancy K. [1 ]
机构
[1] Evidera, Bethesda, MD USA
来源
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION | 2018年 / 5卷 / 01期
关键词
COPD; exacerbations; EXACT; patient-reported outcomes; outcome measures; health status; lung function; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; RESPIRATORY SYMPTOMS; NEUTROPHIL ELASTASE; CLINICAL-TRIALS; GLOBAL BURDEN; TIME-COURSE; TOOL EXACT; DIARY; QUESTIONNAIRE;
D O I
10.15326/jcopdf.5.1.2017.0166
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: This study examined the short-term effects of symptom-defined exacerbation recovery on health status and pulmonary function in moderate to severe chronic obstructive pulmonary disease (COPD) patients. Methods: Secondary analyses of pooled data from two 12-week Phase II international, randomized controlled trials using the EXAcerbations of Chronic Pulmonary Disease Tool (EXACT) to identify symptom-defined exacerbations were conducted. Recovery was categorized as recovered, unrecovered (persistent worsening), or censored. Multiple regression analyses were used to test the effect of recovery status on change in the St George's Respiratory Questionnaire (SGRQ) and forced expiratory volume in 1 second (FEV1) from baseline to Week 12. Evaluating Respiratory Symptom scale (E-RS) scores were used to evaluate change in stable-state respiratory symptoms from baseline to Week 12. Results: Of 1346 eligible patients, 414 (31%) experienced >= 1 symptom-defined exacerbation; 260 patients recovered from their events, 80 experienced an unrecovered event (persistent worsening), 74 patients had only censored events (excluded). Groups were similar at baseline, with the recovered group reporting significantly worse symptoms (p<0.01). Recovery group and baseline SGRQ were significant predictors of change in health status over 12 weeks (p=0.04; p<0.01); no effects were observed for lung function. Significant between-group differences in change in respiratory symptom severity from baseline to Week 12 were observed (p<0.01), with the persistent worsening group experiencing clinically meaningful deterioration in breathlessness and chest symptoms. Conclusions: Results suggest some patients have difficulty recovering from symptom-defined exacerbations, leading to a deterioration in health status, dyspnea, and chest symptoms without short-term effects on lung function. Further study of symptom-defined exacerbation recovery and health outcomes is warranted.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 50 条
  • [1] The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
    Atis, Sibel
    Ozgur, Eylem
    Ozge, Cengiz
    Duman, Yasin
    Tastekin, Esin
    Ilvan, Ahmet
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
    Jochmann, Anja
    Scherr, Andreas
    Jochmann, Dirk Christian
    Miedinger, David
    Toeroek, Salome Schafroth
    Chhajed, Prashant N.
    Tamm, Michael
    Leuppi, Joerg Daniel
    SWISS MEDICAL WEEKLY, 2012, 142
  • [3] Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review
    Machado, A.
    Barusso, M.
    De Brandt, J.
    Quadflieg, K.
    Haesevoets, S.
    Daenen, M.
    Thomeer, M.
    Ruttens, D.
    Marques, A.
    Burtin, C.
    PULMONOLOGY, 2023, 29 (06): : 518 - 534
  • [4] Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD
    Ramlal, S. K.
    Visser, F. J.
    Hop, W. C.
    Dekhuijzen, P. N. R.
    Heijdra, Y. F.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 173 (01) : 58 - 63
  • [5] Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD
    Ke, Xuehua
    Marvel, Jessica
    Yu, Tzy-Chyi
    Wertz, Debra
    Geremakis, Caroline
    Wang, Liya
    Stephenson, Judith J.
    Mannino, David M.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1689 - 1703
  • [6] Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone
    Kurashima, Kazuyoshi
    Hara, Kenichirou
    Yoneda, Kouichirou
    Kanauchi, Tetsu
    Kagiyama, Naho
    Tokunaga, Daido
    Takayanagi, Noboru
    Ubukata, Mikio
    Sugita, Yutaka
    RESPIROLOGY, 2009, 14 (02) : 239 - 244
  • [7] Short-term follow-up after acute COPD exacerbation
    Le Guillou, F.
    REVUE DES MALADIES RESPIRATOIRES, 2017, 34 (04) : 410 - 412
  • [8] The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
    Miravitlles, Marc
    Chapman, Kenneth R.
    Chuecos, Ferran
    Ribera, Anna
    Gil, Esther Garcia
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2041 - 2053
  • [9] Short-term telemonitoring program after hospital discharge for COPD exacerbation: Greek pilot of the renewing health multicenter randomized trial
    Kerenidi, Theodora
    Stafyla, Eirini
    Dafoulas, George
    Giannakakos, Haralabos
    Pinaka, Maria
    Karetsi, Eleni
    Stafylas, Panagiotis
    Theodorou, Kiriaki
    Pexlivanoglou, Petros
    Mavrodi, Fenia
    Aletras, Vasileios
    Gourgoulianis, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD
    Crisafulli, Ernesto
    Manco, Alessandra
    Guerrero, Monica
    Ceccato, Adrian
    Huerta, Arturo
    Gabarrus, Albert
    Girelli, Domenico
    Soler, Nestor
    Torres, Antoni
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (02) : 401 - 408